Six-Minute Walk Distance and Long-Term Outcomes in Contemporary Left Ventricular Assist Device Recipients: The ELEVATE Registry
Interdisciplinary CardioVascular and Thoracic Surgery · 03.11.2026 · 41 (11)
DOI: 10.1093/icvts/ivag241 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 11.09.2026. Verfasst von William Herrik Nielsen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Failure, Walk Test, Ventricular Function, Left. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott.
Abstract (Originalsprache)
Objectives
This study aimed to assess the prognostic value of six-minute walk distance (6MWD) in stable HeartMate 3 (HM3) recipients.
Methods
Data from patients with available 6MWD at 6 months post-implant were obtained from the prospective, multicentre ELEVATE registry. Overall survival and adverse event rates were analysed using Cox regression models adjusted for age and sex, with 6MWD as a continuous predictor, and stratified by median distance (350 m).
Results
Six-minute walk distance at 6 months was available in 194 HM3 recipients. Patients walking < median were older (57 vs 52 years, P = .002), had more comorbidities, and reported lower quality of life. Six-minute walk distance correlated positively with haemoglobin (r = 0.20, P = .006) and EuroQoL-5 Dimensions visual analogue scale (EQ-5D VAS) (r = 0.23, P = .004), and inversely with New York Heart Association (NYHA) class (r = –0.47, P < .0001). Kaplan-Meier analyses of patients walking < or ≥ 350 m showed no significant differences in survival (log-rank P = .379), right heart failure (HF) (P = .334), or rehospitalization (P = .243), while survival free from haemocompatibility-related adverse events differed significantly, although marginally (P = .049). Cox models confirmed that 6MWD had no independent prognostic value for mortality (HR 0.98, 95% CI, 0.96-1.01, P = .26) or secondary outcomes. However, patients with < median 6MWD experienced higher rates of major bleeding (Incidence rate ratio (IRR) 2.88, P < .001), major infection (IRR 2.14, P < .0001), and renal dysfunction (IRR 4.78, P = .033).
Conclusions
Shorter 6MWD 6 months after HM3 implantation was associated with a higher risk of some adverse events (AEs) but was not prognostic for mortality, HF recurrence, or rehospitalization risk. The prognostic value of 6MWD in HF patients without circulatory support cannot be extrapolated to patients treated with current left ventricular assist devices (LVADs). Clinical trial registration number ClinicalTrials.gov Identifier: NCT02497950.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen 2200, Denmark.
- Heart Failure Division, Abbott Cardiovascular, Abbott Park, IL 60064, United States.
- The Transplant Centre, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester M23 9LT, United Kingdom.
- Department of Cardiothoracic Surgery, Klinikum Links der Weser, Bremen 28277, Germany.
- Department of Cardiothoracic Surgery, Herz- und Diabeteszentrum NRW, Bad Oeynhausen 32545, Germany.
ORCID-Profile: William Herrik Nielsen, Finn Gustafsson, Steven Shaw, Jens Garbade, Michiel Morshuis, Daniel Zimpfer, Jacob Lavee, Laura Walker, Carlye Kraemer, Carlo Gazzola, Diyar Saeed
Förderung
- Abbott
Zitieren
APA
Nielsen, W. H., Gustafsson, F., Shaw, S., Garbade, J., Morshuis, M., Zimpfer, D., Lavee, J., Walker, L., Kraemer, C., Gazzola, C., Saeed, D., & ELEVATE Registry Investigators (2026). Six-Minute Walk Distance and Long-Term Outcomes in Contemporary Left Ventricular Assist Device Recipients: The ELEVATE Registry. Interdisciplinary CardioVascular and Thoracic Surgery, 41(11). https://doi.org/10.1093/icvts/ivag241
Vancouver
Nielsen WH, Gustafsson F, Shaw S, Garbade J, Morshuis M, Zimpfer D, et al. Six-Minute Walk Distance and Long-Term Outcomes in Contemporary Left Ventricular Assist Device Recipients: The ELEVATE Registry. Interdisciplinary CardioVascular and Thoracic Surgery. 2026;41(11). doi:10.1093/icvts/ivag241
BibTeX
@article{Nielsen2026,
author = {Nielsen, William Herrik and Gustafsson, Finn and Shaw, Steven and Garbade, Jens and Morshuis, Michiel and Zimpfer, Daniel and Lavee, Jacob and Walker, Laura and Kraemer, Carlye and Gazzola, Carlo and Saeed, Diyar and ELEVATE Registry Investigators, ELEVATE Registry Investigators},
title = {Six-Minute Walk Distance and Long-Term Outcomes in Contemporary Left Ventricular Assist Device Recipients: The ELEVATE Registry},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2026},
volume = {41},
number = {11},
doi = {10.1093/icvts/ivag241}
}
EUVIMED